About Incor Pharma and Diagnostics Private Limited
Data last updated:
Incor Pharma and Diagnostics Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Incor Hospitals Private Limited. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 22 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85110TG2012PTC084319.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shrihari Pulagam and Gautham Reddy Madduri.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor Vijetha Midas Touch Apartments Sy No.6, White Field Road Kondapur Hyderabad, Telangana, India – 500084.
The company has 1 deal on record (1 secondary share transfer); the latest was in December 2013.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website incor.in.
CIN History
Incor Pharma and Diagnostics has one previous CIN (Corporate Identification Number): U85110AP2012PTC084319. The current CIN is U85110TG2012PTC084319, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110TG2012PTC084319 | Current |
| U85110AP2012PTC084319 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressGround Floor Vijetha Midas Touch Apartments Sy No.6, White Field Road Kondapur Hyderabad, Telangana, India – 500084
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Incor Pharma and Diagnostics Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2017-18 to FY 2020-21in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | •••• | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | •••• | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2021-22 | FY 2017-18 to FY 2020-21in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | •••• | |
| Net Profit Margin | •••• | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2017-18 to FY 2020-21, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Incor Pharma and Diagnostics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrihari Pulagam | Director | 25 May 2022 | 4 Years 4 Months | Current |
| Gautham Reddy Madduri Also directs: Omnipharm Laboratories Private Limited | Director | 22 Nov 2012 | 13 Years 11 Months | Current |
Auditor Details
Incor Pharma and Diagnostics Private Limited is audited by K C P & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K C P & CO | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Incor Pharma and Diagnostics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding
Incor Pharma and Diagnostics Private Limited has 1 deal on record (1 secondary share transfer); the latest was in December 2013.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2013 | Secondary share transfer | Undisclosed | Buyer: Incor Hospitals Private Limited Seller: an individual |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Incor Pharma and Diagnostics.
: available in the company report
Recent Activity
Incor Pharma and Diagnostics Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Shrihari Pulagam ceased to be Additional Director on 26 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Related news
Frequently Asked Questions
Incor Pharma and Diagnostics is an active private limited company based in Hyderabad, Telangana, India. The company works in hospitals, within the healthcare industry. It was incorporated on 22 November 2012 (14+ years old) and is registered under CIN U85110TG2012PTC084319.
Incor Pharma and Diagnostics has 2 current directors:
- Shrihari Pulagam - Director
- Gautham Reddy Madduri - Director
The latest financial statements of Incor Pharma and Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Incor Pharma and Diagnostics is U85110TG2012PTC084319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Incor Pharma and Diagnostics was incorporated on 22 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Incor Pharma and Diagnostics has 1 deal on record (1 secondary share transfer); the latest was in December 2013.
Shrihari Pulagam ceased to be Additional Director on 26 Sep 2022. Shrihari Pulagam was appointed as Director on 25 May 2022. Upendar Reddy Singatala ceased to be Director on 25 May 2022. Incor Pharma and Diagnostics has 5 board changes on record in total.
Incor Pharma and Diagnostics can be reached through the website incor.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Incor Pharma and Diagnostics is at Ground Floor Vijetha Midas Touch Apartments Sy No.6, White Field Road Kondapur Hyderabad, Telangana, India – 500084.
Incor Pharma and Diagnostics operates in the healthcare industry, in the hospitals segment.